|
 |
Click here to read about Dr. Laufer performing
a Stent procedure and providing commentary on a Renal Stent procedure
during a live webcast at Good Samaritan Regional Medical Center. |
Research
Dr. Laufer has been an integral part of cardiovascular
research and development since 1987. His most recent endeavors as principal
investigator include such highly recognized studies as:
Cordis Sirius stent trial, 2001
Accumetrics Ultegra System testing RPFA- ADP in citrate and PPACK,
2001
Biocompatibles Stent for Abrupt or threatened closure, 2001
Cordis Carotid Stent with Angioguard Distal Protection, 2000
Angioseal Slipknot Puncture Closure Device, 6F & 8F, 2000
AVE S7 Stent, 2000
SVG High scaffolding Registry (Colossus Trial) AVE, 2000
Carotid Stent Trial, Good Samaritan Hospital, 2000
Intratherapeutics renal stent (Restore Trial), 2000
Safer Trial (Percusurge vein graft protection vs. placebo, 1999-2000
Neurex CABG renal protection trial, 1999: Cancelled.
Boston Scientific IBIS Coronary Radiation Trial, 1999
Guidant Neocardia B Radiation, 1999-2000
Soar Trial (AVE renal stent vs. Palmaz stent), 1999
Velocity Trial (Bx Velocity for abrupt or threatened closure,
J&J), 1999
Predict Trial (AVE Primary Stenting vs. Predilation), 1999
Publications
Dr. Laufer has published numerous abstracts, manuscripts, and articles
in highly prestigious magazines and journals on his findings in scientific
research and the technological advancements in treating coronary artery
disease. His most recent publications are:
Speed Group, Gusto-4 Pilot Group, Trial of Abeiximab with and without
Low-dose Reteplase for Acute Myocardial Infarction. Accepted for publication.
Nirvana Investigators: A Randomized Trial Comparing the NIR Stent to
the Palmaz-Schatz Stent in Native Coronary Lesions. Submitted for publication.
Sandoval A, Laufer N: Iatrogenic Brain Attack: Treatment and/or Prevention?
Cathet. Cardiovasc. Diag.
Sandoval A, Laufer N: Graft Thrombolysis Complicated by Acute Stroke:
Salvage with Local Intracerebral TPA Infusion. Cathet. Cardiovasc. Diag.
The Pursuit Trial Investigators: Inhibition of Platelet Glycoprotein
IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes.
N Engl. J Med.
Dr. Laufers scientific presentations have been recognized by
and presented at such prestigious institutions as the American College
of Physicians and the Inter-American Congress of Cardiology. He also
has been invited on many occasions to speak at medical centers and hospitals,
university medical schools and colleges across North America.
Awards
2000
Listed in The National
Registry of Whos Who
1998
Listed in Phoenix Business
Journal Whos Who in
Heatlhcare
1997
Listed in Phoenix Business Journal Survey of Most
Influential in Health Care
1998 - 2001
Listed in Marquis
Whos Who in the World
Listed in Marquis Whos Who in America
Listed in Marquis Whos Who in the West
Listed in Marquis Whos Who in Science and
Engineering
Top Doc-Cardiovascular Disease, Phoenix Magazine
1997
Top Docs-Cardiovascular
Disease,
Phoenix Magazine, Nurses Survey
1997 - 2000
Listed in Marquis
Whos Who in
Medicine and Healthcare
1996 - 1997
Listed in Best
Doctors in America: Pacific Region
1996
Top Docs-Cardiovascular
Disease,
Phoenix Magazine, Woodward/White Survey
1995
Best Doctor Award-Cardiac Catheterization,
Phoenix Magazine, Physician
Survey
1986
-1987
Teacher of the Year, Good Samaritan Regional
Medical Center
1971
- 1976
McGill University Scholarship
Dr. Laufer's Web Page
Click
here to go to Dr. Laufer's personal web page.
|